Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-13071Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-14399Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-15670Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-16608Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-17252Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-21620Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-23271Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-24785Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-30231Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M-H)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+5513Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+10980Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+11492Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+11724Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+12254Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+13410Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+13941Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+14504Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+14759Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+23245Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEOPHTHALMIC ACID (CAS# 495-27-2); (M+H)+Peak areaPAK Untreated

Return to search page
  logo